Literature DB >> 23408521

Regional immune response to immunization with Escherichia coli O157:H7-derived intimin in cattle.

Kathryn G Boland1, Andrea N Hayles, Claire B Miller, Tovah Kerr, Wendy C Brown, Kevin K Lahmers.   

Abstract

Escherichia coli O157:H7 is an enteric pathogen of animals and humans that can result in deadly sequelae. Cattle are asymptomatic carriers and shedders of the bacteria and serve as an important reservoir of human infection. E. coli O157:H7 colonizes the gastrointestinal tract, most frequently at the rectoanal junction mucosa in cattle. Vaccination is a potentially highly effective means of decreasing cattle colonization and shedding and thereby decreasing human infections. Currently available vaccines are administered subcutaneously or intramuscularly, and immune responses have been evaluated solely by systemic immunoglobulin responses. This study evaluated local and systemic lymphoproliferative responses in addition to immunoglobulin responses following subcutaneous or mucosal (rectal) immunization with E. coli O157:H7 outer membrane protein intimin over three trials. In all three trials, significant local and systemic lymphoproliferative responses (P < 0.05) occurred following immunization in the majority of animals, as well as significant immunoglobulin responses (P < 0.001) in all animals. Surprisingly, local responses in the mesorectal lymph nodes were very similar between the subcutaneous and mucosal immunization groups. Moreover, the responses in mesorectal lymph nodes appeared targeted rather than generalized, as minimal or no significant responses were observed in the associated prescapular lymph nodes of subcutaneously immunized animals. The results indicate that both subcutaneous and mucosal immunizations are effective methods of inducing immune responses against E. coli O157:H7 in cattle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408521      PMCID: PMC3623412          DOI: 10.1128/CVI.00743-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  56 in total

1.  Outbreaks of Escherichia coli O157:H7 infection and cryptosporidiosis associated with drinking unpasteurized apple cider--Connecticut and New York, October 1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-01-10       Impact factor: 17.586

2.  Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin.

Authors:  Tonia S Agin; Chengru Zhu; Laura A Johnson; Timothy E Thate; Zhuolu Yang; Edgar C Boedeker
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  J Yu; J B Kaper
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

4.  The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

Authors:  S Dundas; W T Todd; A I Stewart; P S Murdoch; A K Chaudhuri; S J Hutchinson
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection.

Authors:  Evelyn A Dean-Nystrom; Lisa J Gansheroff; Melody Mills; Harley W Moon; Alison D O'Brien
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 6.  Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells.

Authors:  R DeVinney; A Gauthier; A Abe; B B Finlay
Journal:  Cell Mol Life Sci       Date:  1999-06       Impact factor: 9.261

Review 7.  The imidazoquinolines and their place in the therapy of cutaneous disease.

Authors:  Kathleen J Smith; Sate Hamza; Henry Skelton
Journal:  Expert Opin Pharmacother       Date:  2003-07       Impact factor: 3.889

8.  The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia.

Authors:  D B Schauer; S Falkow
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Simple methods for measurement of bovine mucosal antibody responses in vivo.

Authors:  Tom N McNeilly; Stuart W Naylor; Mairi C Mitchell; Sean McAteer; Arvind Mahajan; David G E Smith; David L Gally; J Christopher Low; John F Huntley
Journal:  Vet Immunol Immunopathol       Date:  2007-05-03       Impact factor: 2.046

10.  Modulation by colostrum-acquired maternal antibodies of systemic and mucosal antibody responses to rotavirus in calves experimentally challenged with bovine rotavirus.

Authors:  V Parreño; C Béjar; A Vagnozzi; M Barrandeguy; V Costantini; M I Craig; L Yuan; D Hodgins; L Saif; F Fernández
Journal:  Vet Immunol Immunopathol       Date:  2004-07       Impact factor: 2.046

View more
  2 in total

1.  Mucosal Immune Profiles Associated with Diarrheal Disease Severity in Shigella- and Enteropathogenic Escherichia coli-Infected Children Enrolled in the Global Enteric Multicenter Study.

Authors:  Amanda D Buskirk; Esther Ndungo; Avital A Shimanovich; Diana Lam; William C Blackwelder; Usman N Ikumapayi; Bing Ma; Helen Powell; Martin Antonio; James P Nataro; James B Kaper; Marcela F Pasetti
Journal:  mBio       Date:  2022-08-04       Impact factor: 7.786

2.  Antibodies Directed against Shiga-Toxin Producing Escherichia coli Serotype O103 Type III Secreted Proteins Block Adherence of Heterologous STEC Serotypes to HEp-2 Cells.

Authors:  Taseen S Desin; Hugh G Townsend; Andrew A Potter
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.